← back to search

Ling Zhang

Guangzhou University of Chinese Medicine · CN

Area of research

Cancer Research · Molecular Biology

Research interest

Research focused on Downregulation and upregulation and Cell growth, with related work in Cancer research, microRNA, Cell cycle. Notable publications include 'miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation', 'Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer', and 'Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis'.

h-index

—

citations

149

works

3

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

Retrospective analysis of the curative effect of Kanglaite injection on pancreatic cancer

Journal of Medical Biochemistry 2025cited by 0position: middledoi

Immune-tumor interaction dictates spatially directed evolution of esophageal squamous cell carcinoma

National Science Review 2024cited by 18position: middledoi

Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis

RNA Biology 2020cited by 54position: firstdoi

Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer

Journal of Experimental & Clinical Cancer Research 2017cited by 71position: middledoi

Artesunate altered cellular mechanical properties leading to deregulation of cell proliferation and migration in esophageal squamous cell carcinoma

Oncology Letters 2015cited by 31position: middledoi

miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation

European Journal of Cancer 2013cited by 78position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaolong Cheng · Shanxi Medical University2 papers (2015–2024)Yongping Cui · Shanxi Medical University2 papers (2015–2024)Heyang Cui · Shanxi Medical University2 papers (2015–2024)Bin Yang · Shanxi Provincial Cancer Hospital2 papers (2015–2024)Ruifang Sun · Xi'an Jiaotong University1 papers (2024–2024)Bin Song · Shanghai Medical College of Fudan University1 papers (2015–2015)Hongjuan Ji · Nanjing University of Chinese Medicine1 papers (2025–2025)Yikun Cheng · University of California, Berkeley1 papers (2024–2024)Fang Wang · Fudan University1 papers (2015–2015)Wei Zhu · Beijing Information Science & Technology University1 papers (2013–2013)Shuaishuai Xiao · Shanxi Medical University1 papers (2015–2015)Yanfeng Xi · Hangzhou Cancer Hospital1 papers (2024–2024)Zhi-jie Du · Shanxi Medical University1 papers (2015–2015)Chonghui Zhao · Jiangsu University1 papers (2013–2013)Xun Huang · South China Agricultural University1 papers (2015–2015)Ziling Fang · Tulane University1 papers (2017–2017)Xian Miao · Nanjing University of Chinese Medicine1 papers (2025–2025)Jian Ruan · Nanjing University of Chinese Medicine1 papers (2025–2025)Shanlan Mo · Shenzhen Institutes of Advanced Technology1 papers (2024–2024)Dawei Qiao · Nanjing University of Chinese Medicine1 papers (2025–2025)